Prognostic value of analysing the bioimpedance vector for patients hospitalised for acute decompensated heart failure: A validation cohort;Valor pronóstico del análisis del vector de bioimpedancia en pacientes ingresados por descompensación aguda de insuficiencia cardiaca: cohorte de validación

Revista Clinica Espanola

Volumn 216, Issue 3, 2016, Pages 121-125

  Trejo Velasco, B ^a   Fabregat Andres O ^a   Montagud, V ^a   Morell, S ^a   Nunez J ^b   Facila L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Bioimpedance; Heart failure; Prognostic stratification; Systemic congestion

Indexed keywords

ACUTE HEART FAILURE; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; FOLLOW UP; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY;

EID: 84955310171     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2015.12.004     Document Type: Article

References (15)

1. 1 Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 129 (2014), 399–410.
2. 2 Gheorghiade, M., Vaduganathan, M., Fonarow, G.C., Bonow, R.O., Rehospitalization for heart failure: Problems and perspectives. J Am Coll Cardiol 61 (2013), 391–403.
3. 3 Gheorghiade, M., Follath, F., Ponikowski, P., Barsuk, J.H., Blair, J.E., Cleland, J.G., et al., European Society of Cardiology; European Society of Intensive Care Medicine. Assessing and grading congestion in acute heart failure: A scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12 (2010), 423–433.
4. 4 Gheorghiade, M., Filippatos, G., de Luca, L., Burnett, J., Congestion in acute heart failure syndromes: An essential target of evaluation and treatment. Am J Med 119:Suppl 1 (2006), S3–S10.
5. 5 Bettencourt, P., Azevedo, A., Pimenta, J., Frioes, F., Ferreira, S., Ferreira, A., N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004), 2168–2174.
6. 6 Piccoli, A., Pittoni, G., Facco, E., Favaro, E., Pillon, L., Relationship between central venous pressure and bioimpedance vector analysis in critically ill patients. Crit Care Med 28 (2000), 132–137.
7. 7 Di Somma, S., Lalle, I., Magrini, L., Russo, V., Navarin, S., Castello, L., et al. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide ‘grey-zone’ in patients with acute heart failure in the emergency department. Eur Heart J Acute Cardiovasc Care 3 (2014), 167–220.
8. 8 Núñez, J., Mascarell, B., Stubbe, H., Ventura, S., Bonanad, C., Bodí, V., et al. Bioelectrical impedance vector analysis and clinical outcomes in patients with acute heart failure. J Cardiovasc Med (Hagerstown), 2014 [Epub ahead of print].
9. 9 McMurray, J., Adamopoulos, S., Anker, S., Auricchio, A., Böhm, M., Dickstein, K., et al. Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012. Rev Esp Cardiol 65 (2012), e1–e59.
10. 10 Valle, R., Aspromonte, N., Milani, L., Peacock, F.W., Maisel, A.S., Santini, M., et al. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): The emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 16 (2011), 519–529.
11. 11 Marino, R., Magrini, L., Ferri, E., Gagliano, G., di Somma, S., B-Type natriuretic peptide and non-invasive haemodynamics and hydration assessment in the management of patients with acute heart failure in emergency department. High Blood Press Cardiovasc Prev 17 (2010), 219–225.
12. 12 Testani, J.M., Chen, J., McCauley, B.D., Kimmel, S.E., Shannon, R.P., Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122 (2010), 265–272.
13. 13 Felker, G.M., O'Connor, C.M., Braunwald, E., Loop diuretics in acute decompensated heart failure: Necessary? Evil? A necessary evil. Circ Heart Fail 2 (2009), 56–62.
14. 14 Cerqueiro, J.M., González-Franco, A., Montero-Perez-Barquero, M., Llácer, P., Conde, A., Davila, M.F., et al. Reducción de ingresos y visitas a Urgencias en pacientes frágiles con insuficiencia cardiaca: resultados del programa asistencias UMIPIC. Rev Clin Esp, 2015, 10.1016/j.rce.2015.07.006 [Epub ahead of print].
15. 15 Di Somma, S., Navarin, S., Giordano, S., Spadini, F., Lippi, G., Cervellin, G., et al. The emerging role of biomarkers and bio-impedance in evaluating hydration status in patients with acute heart failure. Clin Chem Lab Med 50 (2012), 2093–2105.